Moleculin Biotech (MBRX) Misses Q2 EPS by 49c

Moleculin Biotech (NASDAQ: MBRX) reported Q2 EPS of ($0.49).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• New York Fed raises Q3 2026 GDP forecast to 2.3%
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"